Pure Bioscience

(OTC) PURE

Current Price$0.06

Market Cap$7.23M

Since IPO (1996)-100%

5 Year-88%

1 Year-9%

1 Month-18%

Pure Bioscience Financials at a Glance

Market Cap

$7.23M

Revenue (TTM)

$2.42M

Net Income (TTM)

-$2.21M

EPS (TTM)

-$0.02

P/E Ratio

-2.81

Dividend

$0.00

Beta (Volatility)

0.21 (Low)

Dividend

$0.00

Beta (Volatility)

0.21 (Low)

Price

$0.06

Volume

96,288

Open

$0.07

Price

$0.06

Volume

96,288

Open

$0.07

Previous Close

$0.06

Daily Range

$0.06 - $0.07

52-Week Range

$0.04 - $0.14

Estimated Earnings Date

Jun 16, 2026

Dividend

$0.00

Beta (Volatility)

0.21 (Low)

Price

$0.06

Volume

96,288

Open

$0.07

Previous Close

$0.06

Daily Range

$0.06 - $0.07

52-Week Range

$0.04 - $0.14

Estimated Earnings Date

Jun 16, 2026

PURE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pure Bioscience

Industry

Household Products

Sector

Consumer Staples

Employees

CEO

Robert F. Bartlett

Website

www.purebio.com

Headquarters

El Cajon, CA 92019, US

PURE Financials

Key Financial Metrics (TTM)

Gross Margin

53803.55%

Operating Margin

-79.11%

Net Income Margin

-91.04%

Return on Equity

38.73%

Return on Capital

N/A

Return on Assets

-141.53%

Earnings Yield

-35.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.23M

Shares Outstanding

130.02M

Volume

96.29K

Avg. Volume

33.89K

Financials (TTM)

Gross Profit

$1.30B

Operating Income

-$1.92M

EBITDA

$185.00K

Operating Cash Flow

-$1.78M

Capital Expenditure

$0.00

Free Cash Flow

-$1.78M

Cash & ST Invst.

$983.00K

Total Debt

$6.50M

Pure Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$506.00K

+3.1%

Gross Profit

$269.00K

-4.9%

Gross Margin

53.16%

N/A

Market Cap

$7.23M

N/A

Market Cap/Employee

$602.42K

N/A

Employees

N/A

Net Income

-$624.00K

-7.6%

EBITDA

-$518.00K

-3.4%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

$983.00K

+82.0%

Total Debt

$6.50M

+32.6%

Accounts Receivable

$242.00K

-15.7%

Inventory

$232.00K

+77.1%

Long Term Debt

$3.74M

-23.6%

Short Term Debt

$2.75M

N/A

Return on Assets

-1.42%

N/A

Return on Invested Capital

91.41%

N/A

Free Cash Flow

-$468.00K

+8.6%

Operating Cash Flow

-$468.00K

+8.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DQWSDSwiss, Inc.

DQWSDSwiss, Inc.$0.04+0.00%

EXDWExceed World, Inc.

EXDWExceed World, Inc.$0.29+0.00%

CAWWCCA Industries, Inc.

CAWWCCA Industries, Inc.$0.48+0.00%

HERBYaSheng Group

HERBYaSheng Group$0.02-22.56%

HIGRHi-Great Group Holding Company

HIGRHi-Great Group Holding Company$0.03+0.00%

NUVIEmo Capital Corp.

NUVIEmo Capital Corp.$0.02-99.47%

NPRFFNepra Foods Inc.

NPRFFNepra Foods Inc.$0.21-47.31%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

NOKNokia

NOKNokia$12.07-0.07%

RIVNRivian Automotive

RIVNRivian Automotive$18.63+0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.95+0.05%

Questions About PURE

What is the current price of Pure Bioscience?

Pure Bioscience is trading at $0.06 per share.

What is the 52-week range for Pure Bioscience?

Over the past 52 weeks, Pure Bioscience has traded between $0.04 and $0.14.

How much debt does Pure Bioscience have?

As of the most recent reporting period, Pure Bioscience reported total debt of $6.50M.

How much cash does Pure Bioscience have on hand?

Pure Bioscience reported $1.06M in cash and cash equivalents in its most recent financial results.

What is Pure Bioscience’s dividend yield?

Pure Bioscience does not currently have a dividend yield.

Pure Bioscience

Pure Bioscience Financials at a Glance

PURE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Pure Bioscience

PURE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Pure Bioscience Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PURE

What is the current price of Pure Bioscience?

What is the 52-week range for Pure Bioscience?

How much debt does Pure Bioscience have?

How much cash does Pure Bioscience have on hand?

What is Pure Bioscience’s dividend yield?

Premium Investing Services